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Canine Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are uncommonly reported in the ulnar, since they are
underestimated relative to the more common spindle cell tumours of soft tissue. In dogs, MPNST accounts for 27%
of nervous system tumours. In man, MPNST represents 5-10% of all soft tissue sarcomas and is often associated
with neurofibromatosis type 1 (NF-1).An 8-year-old, 9 kg, female mixed-breed dog with a subcutaneous mass on
the upper right side of the ulnar region was presented to the small animal research and teaching hospital of
Tehran University. The dog was anorexic with general weakness. The mass (7 × 4 cm) was removed surgically and
processed routinely. Microscopically, the mass was composed of highly cellular areas with a homogeneous
population of round or spindle cells, high cellular pleomorphism, high mitotic index and various morphologic
patterns. Furthermore, spindle cells arranged in densely or loosely sweeping fascicles, interlacing whorls, or
storiform patterns together with wavy cytoplasm, nuclear palisades, and round cells were arranged in sheets or
cords with a meshwork of intratumoral nerve fibers. In addition, in this case the presence of neoplastic cells within
the blood vessels was observed. Immunohistochemically, tumor was positive for vimentin and S-100 protein. The
histopathologic features coupled with the S-100 and vimentin immunoreactivity led to a diagnosis of malignant
neurofibroma.
To the best of our knowledge, primary ulnar MPNST has not been reported in animals. This is the first
documentation of an ulnar malignant peripheral nerve sheath tumour in a dog.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1310907815984587
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TRBackgroundCanine peripheral nerve sheath tumors (PNSTs) are un-commonly reported, and their clinical behavior has not
been well documented [1,2]. These tumors are relatively
common in humans but occur infrequently in domestic
animals [3]. Based on the morphologic and biologic
behavior, PNSTs are divided to benign PNST (BPNST)
and malignant PNST (MPNST) forms with several* Correspondence: javadjavanbakht@ut.ac.ir
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reproduction in any medium, provided the ormorphologic features [1-3]. MPNST is an aggressive and
uncommon neoplasm that develops within peripheral
nerve [4].
In human MPNSTs, variable histologic patterns and
heterogenous differentiation have been reported [5-7], in-
cluding epithelioid MPNST [8,9] and MPNST with diver-
gent differentiation such as rhabdomyoblastic (malignant
Triton tumor) [10-12] cartilaginous, osseous, angiomatous
[13] and glandular forms [14,15], or their complex [16].
Similar representation such as epithelioid type [17], mel-
anotic type [18,19] cartilaginous and osteogenic [20] orl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.





glandular epithelial differentiation have been found in
MPNSTs in dogs or other animals [3,21].
Histologically, in human MPNSTs, the malignant nature
of these tumours were evident upon their microscopic in-
spection, as they were comprised of an infiltrative and cel-
lular proliferation of atypical, mitotically active spindle
cells. Most MPNSTs are high-grade tumours with a
high mitotic rate and commonly induce necrosis. The
most common histological patterns include a high-
grade fibrosarcomatous mass composed of densely
packed sheets of plump but relatively uniform spindle
or oval cells [4,22-26].
Immunohistochemical studies have contributed to the
definition of clear diagnostic criteria for PNSTs. In hu-
man medicine, the expression of S-100 protein is used
to differentiate between spindle cell tumours of neural
and non-neural origins [27]. In veterinary medicine, im-
munohistochemical detection of S-100 and vimentin has
been able to distinguish conclusively between subsets of
such spindle cell tumours [28].
This report describes the histologic and immunohisto-
chemical diagnosis of a neurofibrosarcoma in the ulnar
of a dog.
Case presentation
An 8-year-old, 9 kg, female, mixed-breed dog referred to
the Small Animal Clinic of Tehran University. Clinical
examination revealed a rapidly growing, nodular, sub-
cutaneous mass, 7×4 cm in diameter, invading and
strongly adhering to the underlying tissue. The mass was
located on the upper right side of the ulnar region. The
dog had anorexia, general weakness and inability to
stand. Ultrasonography revealed a subcutaneous mass
with a central depth of 5.4 cm. ventrally, the margins of
the lesion appeared to be well defined and the abdom-
inal organs were not visibly affected.
The blood cell count was undertaken manually and
calcium and phosphorus concentration were measured
by commercial kits (Pars Azmoon, Alborz, Iran) using a
semi-automatic analyzer (EMP 168 Vet Biochemical
analyzer; Shenzhen Emperor Electronic technology Co.
Ltd, Shenzhen, China). Haematological and biochemical
profiles (including blood cell count and serum calcium
and phosphorus concentrations) were within normal
ranges.
For partial excisional biopsy, an intravenous combination
of diazepam (0.27 mg/kg) (Tamin, Tehran, Iran) and keta-
mine hydrochloride (5.50 mg/kg) (Alfasan, Woerden, the
Netherlands) were used for induction and maintenance of
anesthesia and the dog received normal saline solution
0.9% intravenously, to a total of 0.5 L (12 mL/kg/h)
(Samen, Mashhad, Iran). Atropine sulphate (0.03 mg/kg)
(Tamin, Tehran, Iran) was given subcutaneously as pre-




processed routinely. The sample was fixed in formalin and
embedded in paraffin for sectioning. The sections were
stained with haematoxylin and eosin. For further study,
paraffin sections were stained immunohistochemically with
S-100, vimentine markers (Abcam Co., Cambridge, USA).
For immunohistochemistry, sections from tumor
were mounted on adhesive-coated slides (Superfrost
Plus, Menzel-Glaser, Braunschwaig, Germany), processed
through xylene, and rehydrated in ethanol. Antigen re-
trieval was by boiling in a microwave oven (700 W) twice
for 5 minutes in Tris–EDTA buffer—1.21 g Tris base
(A 1379, Applichem, Darmstadt, Germany) and 0.372 g
EDTA (8418, Merck, Darmstadt, Germany)—in 1 liter
of distilled water and pH 9. Endogenous peroxidase
was blocked with 0.6% (v/v) H2O2 in Tris-buffered sa-
line (TBS; pH 7.6) for 15 minutes at 20°C before the anti-
bodies used included those for vimentin (prediluted,
monoclonal: V9), S-100 protein (1:4,800, polyclonal rabbit
anti-S-100).
Histopathology
Histopathologically, neurofibrosarcoma tumour cells were
not circumscribed by connective tissue and neoplastic
cells often exhibited an aggressive behavior, high cellular-
ity, cellular pleomorphism, and various morphologic pat-
terns. Atypical mononuclear or multinucleated cells were
consistently observed. More than three mitotic figures per
high-power field (400×) were found in this case (Figure 1B
and 1C). Necrotic foci accompanied by pseudopalisading
(Figure 2A) and infiltrates of various numbers of lympho-
cytes, plasma cells, and macrophages were common.
In some areas, neurofibrosarcoma was composed mainly
of a homogeneous population of round cells (Figure 1C).
These round cells were arranged in sheets or cords with a
meshwork of intratumoral nerve fibers. The nuclei were
round or oval (Figure 1A and 2B). Furthermore, in some
areas, the spindle cells had long wavy nuclei with tapered
ends. Some had oval, round, short spindle nuclei, or had nu-
clear pseudo-inclusions (Figure 3A, 3B and Figure 1A, 1C).
However, in some regions of the tumor tissue, fusiform
or spindle cells arranged in densely or loosely sweeping
fascicles, interlacing whorls, or storiform patterns to-
gether with wavy cytoplasm, nuclear palisades were pre-
dominant (Figure 2F). In addition, the neoplastic cells
within the blood vessels were observed as well.
Immunohistochemical features of the spindle-shaped neo-
plastic cells were predominantly positive for S-100 and
vimentin (Figure 3A, 3B and 3C) and the cytoplasm and/ or
nucleus of the neoplastic cells were diffusely labeled for ex-
pression of vimentin (Figure 2D), S-100 (Figure 2C and 2E).
Discussion
PNSTs have also been reported in cats, dogs, cattle, rats,








LEFigure 1 A: The cells are in disorganized fascicles with pleomorhism, nuclear atypia and neoplastic spindle cells with wavy eosinophiliccytoplasmic processes. (H & E; bar 20 μm; ×400). B: the neoplastic cells form dense bundles separated by scanty collagenous stroma. Noticebland nuclei lacking atypia. (H & E; bar 30 μm; × 400) C: Upon histopathological examination of the ulnar mass, neurofibroma with a mixture ofround and spindle shaped cells, mitotic figures, infiltrates of various numbers of lymphocytes and hypercellularity arrangement was diagnosed.(H & E; bar 25 μm; × 400).
Figure 2 A: Necrotic focus is accompanied by nuclear pseudopalisading in MPNST, 2B: Neoplastic cells with cytoplasm and round
nuclei are arranged in a cordlike pattern, 2C: The neoplastic cells show diffuse expression of S-100. IHC, 2D: The neoplastic cells show
strong expression of vimentin. IHC 2E: A number of neoplastic cells show a marked cytoplasmic and nuclear immunoreaction for S-100 protein
2F: Fusiform or spindle-shaped neoplasmic cells are arranged in interdacing fascicles.






Figure 3 Immunohistochemical staining with, vimentin (A) and S-100 (B and C) are positive cells; the neoplastic cells in parts of the
neurofibroma express S-100 and vimentin strongly.





been subclassified as neurinomas, neurilemmomas,
schwannoma, neurofibromas, neurofibrosarcomas, and
malignant peripheral nerve sheath tumors (MPNSTs),
based on their presumed cell(s) of origin. In the dog, 2
groups of tumors have been referred to as PNSTs, 1 oc-
curring in the cranial and spinal nerves and 1 occurring
in the skin and subcutaneous [31].
Many of the first group are consistent with MPNSTs and
have metastatic potential [3]. Those occurring in the skin
and subcutaneous of dogs are usually of uncertain histo-
genesis and are referred to by some as hemangiopericytoma
[32]. Palisading, as seen in classic PNSTs, is usually
absent [31].
The histological differentiation between malignant and
benign PNST can be difficult because both may show un-
defined edges and some degree of cellular pleomorphism
[33]. It has been suggested that malignant PNST in dog
have aggressive behavior to intratumoral tissue, extensive
necrotic areas and cellular pleomorphism [34-36]. All of
these characteristics were observed in this case; however,
the presence of neoplastic cells within the blood vessels
was observed that determined the classification of malig-
nancy. A high level of mitosis is also indicative of a malig-
nant PNST [34,36]. In present study, the malignant
histological appearance of the lesion (mitotic index, cellu-
lar pleomorphism or necrosis) occurred in conjunction
with infiltrative growth.
In dogs and humans, divergent differentiation is usu-
ally associated with a poor prognosis [21,37]. The S100Dprotein is the primary marker in the diagnosis ofMPNST (malignant schwannoma, neurofibrosarcoma,
and neurogenic sarcoma) and may be used as a single
diagnostic tool [38,39] or in combination with other
markers such as vimentin [40,41]. The neoplastic cells in
this study showed positivity for S100 and vimentin
immunolabeling.
In this study, based on their morphologic features
diagnostic for human neurofibrosarcoma, i.e., growth
pattern and microscopic features (such as areas of high
cellularity, cellular pleomorphism, various morphologic
patterns, high mitotic index and high number of undif-
ferentiated neoplastic cells), together with the presence
of intratumoral nerve fibers and the restriction of the
S100 and vimentin immunostaining to a subpopulation
of the neoplastic cells, the tumour was diagnosed as
neurofibrosarcoma. But the cause of MPNST in domestic
animals has not yet been determined. Due to its anatom-
ical location and difficulties encountered in complete sur-
gical removal. Canine MPNST often recurs after surgery
and the prognosis is generally poor [42]. In addition, the
prognosis of human patients with primary MPNST is poor
and removal is often followed by recurrence, metastasis
and death [43-45]. No definitive evidence of distant organ
metastasis was found in this case.
Neurofibrosarcoma in this report had marked mor-
phologic variation. The round cell type found in this
case was morphologically similar to the primitive
neuroectodermal tumour described as the small round-
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schwannomas [47], suggesting that the presence of
round cells implies a differentiation toward immature
neural cells.
Immunohistochemical expression of S100 protein and
vimentin by the neoplastic cells prompted consideration
of peripheral nerve sheath tumour in the differential diag-
nosis. Various immunohistochemical markers have been
used to define MPNST. S-100 is commonly expressed in
normal nervous tissue and in most MPNST [48], but also
in most rhabdomyosarcomas and neurofibrosarcoma [49].
The present case was positive for expression of vimentin
and S-100.
On the basis of gross morphology, histopathological
and immunohistochemical features, the final tumour in
this study, a diagnosis of neurofibrosarcoma was made.
For understanding of these complex neoplasms and the
development of the effective differential diagnosis, fur-
ther investigation will be needed into the clinical fea-




This study described histopathology and immunohistochem-
ical features of canine subcutaneous neurofibrosarcoma of
the ulnar region. The histological features of these tumours
would suggest that most should be classified as high-grade
MPNST. A subcutaneous MPNST may be diagnosed on the
basis of observing the histopathological pattern described in
present study. In addition, S-100 and vimentin immu-
nohistochemical expression may be used to help con-
firm the diagnosis of neurofibrosarcoma. Finally, the
use of immunohistochemistry may be helpful in
distinguishing this type of neoplasm from other malig-
nancies with similar morphology. The incidence of
neurofibrosarcoma in animals is unknown; we hope
this will become clearer. To our knowledge, this is the
first report of ulnar MPNST in a dog, suggesting that
this tumour should be included as a differential diag-
nosis for ulnar spindle cell tumours.TCompeting interests
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